| Dr Felix Roa Gaw, MD | |
|
1211 W La Palma Ave, Suite 209, Anaheim, CA 92801-2815 | |
| (714) 533-8885 | |
| (714) 533-8884 |
| Full Name | Dr Felix Roa Gaw |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 1211 W La Palma Ave, Anaheim, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144243601 | NPI | - | NPPES |
| 00A528391 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | A52839 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| La Palma Intercommunity Hospital | La palma, CA | Hospital |
| St Joseph Hospital | Orange, CA | Hospital |
| Placentia Linda Hospital | Placentia, CA | Hospital |
| Entity Name | Caduceus Physicians Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497702724 PECOS PAC ID: 5294762654 Enrollment ID: O20050718001020 |
News Archive
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience.
Health and Human Services Secretary Kathleen Sebelius went to Florida Friday in her campaign to rally support for the new health law. She targeted senior citizens, a crucial voting bloc that polls find is not warming to the bill.
Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis - and to possible treatments - for pathological tissues that are precursors to multiple sclerosis and similar diseases.
› Verified 6 days ago
| Entity Name | Felix R. Gaw, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265749394 PECOS PAC ID: 7214129394 Enrollment ID: O20101007000659 |
News Archive
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience.
Health and Human Services Secretary Kathleen Sebelius went to Florida Friday in her campaign to rally support for the new health law. She targeted senior citizens, a crucial voting bloc that polls find is not warming to the bill.
Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis - and to possible treatments - for pathological tissues that are precursors to multiple sclerosis and similar diseases.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Felix Roa Gaw, MD 2674 E Vista Ridge Dr, Orange, CA 92867-1704 Ph: (714) 533-8885 | Dr Felix Roa Gaw, MD 1211 W La Palma Ave, Suite 209, Anaheim, CA 92801-2815 Ph: (714) 533-8885 |
News Archive
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience.
Health and Human Services Secretary Kathleen Sebelius went to Florida Friday in her campaign to rally support for the new health law. She targeted senior citizens, a crucial voting bloc that polls find is not warming to the bill.
Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis - and to possible treatments - for pathological tissues that are precursors to multiple sclerosis and similar diseases.
› Verified 6 days ago
Bakthan Savarirayan, M.D Surgery Medicare: Not Enrolled in Medicare Practice Location: 3356 W Ball Rd, Suite 205, Anaheim, CA 92804 Phone: 714-761-0332 Fax: 714-761-8792 | |
Larissa R. Tan, MD Surgery Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Gail F. Mattson-gates, MD Surgery Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Leslie B. Rand-luby, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dr. Umer Iqbal Chaudhry, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3430 E La Palma Ave, Anaheim, CA 92806 Phone: 714-644-3359 | |
Mark W. Gow, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |